205 results on '"Kiener H"'
Search Results
2. Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
3. Wertigkeit der CT und des transthorakalen Lungenultraschalls bei PatientInnen mit systemischer Sklerose: Gemeinsame Stellungnahme der ÖRG/ÖGP/ÖGR/ÖGUM
4. POS0030 SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR-T CELL TREATMENT IN RHEUMATIC DISEASE- DATA FROM THE FIRST PART OF THE PHASE I/II CASTLE BASKET STUDY
5. AB0056 CYTOKINE-DIRECTED CELLULAR CROSSTALK IMPRINTS SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS
6. POS0889 ASSESSMENT OF MYOSITIS-RELATED INTERSTITIAL LUNG DISEASE BY68GA-DATA.SA.FAPI PET-CT
7. Entzündliche Gelenkerkrankungen
8. Chronic inflammation predicts long‐term mortality in patients with Raynaudʼs phenomenon
9. Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases–A nationwide, retrospective study
10. Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases–A nationwide, retrospective study
11. Entzündliche Gelenkerkrankungen
12. Gemeinsame deutschsprachige Nomenklatur für die systemische Sklerose
13. POS0446 Arp2/3 AS A Lasp1 INTERACTION PARTNER REGULATES CELL-TO-CELL CONTACT FORMATION OF FIBROBLAST-LIKE SYNOVIOCYTES IN RA
14. OP0079 SYNOVIAL FIBROBLASTS – T CELL INTERACTIONS ARE MAJOR DRIVERS OF INFLAMMATION: A CLOSER LOOK INTO THE JOINT
15. POS0911 DIAGNOSTIC VALUE AND CLINICAL RELEVANCE OF MUSCLE BIOPSY IN PATIENTS WITH SUSPECTED MYOSITIS
16. AB0718 Immune-apheresis in patients with inflammatory myopathies, a case series.
17. P631 Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study
18. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
19. The polyphenols curcumin and resveratrol effectively block IL-1β and PMA-induced IL-6, IL-8 and VEGF-A expression in human rheumatoid synovial fibroblasts
20. IFNγ promotes the invasive behavior of fibroblast-like synoviocytes
21. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
22. Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
23. Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
24. PP2-026 IFNc promotes fibroblast-like synoviocytes motility
25. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control
26. Pleurale und pulmonale Veränderungen im Rahmen der rheumatoiden Arthritis
27. High incidence of asymptomatic urogenital infection in patients with uveitis anterior
28. Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency
29. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study
30. Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis
31. P054 IRF-1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes
32. Immune response-on-chip: microfluidic systems for detecting human inflammatory response to nanomaterials
33. P072 Irf1 is critical for the inflammatory gene expression in fibroblast-like synoviocytes
34. P104 Synovial fibroblast relationship status: it’s complicated
35. Inhibition of janus kinases abrogates the IFN γ-induced activation of the focal adhesion kinase
36. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon
37. FRI0018 Targeted inhibition of janus kinases abates IFN-GAMMA-INDUCED invasive behavior of fibroblast-like synoviocytes
38. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
39. Inhibition of janus kinases abrogates the IFNgamma-induced activation of the focal adhesion kinase
40. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study
41. A7.15 in vitrosilencing of HNRNP-A2/B1 in synovial fibroblasts reveals involvement in regulation of several signal transduction pathways
42. Die hintere Hinterhauptslage
43. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
44. Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
45. Common German language nomenclature for systemic sclerosis
46. AB0075 MTOR: An Unexpected Role on the TNF-Regulated MRNA Transcriptome in Rheumatoid Fibroblast-Like Synoviocytes
47. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
48. CYTOKINE-DIRECTED CELLULAR CROSSTALK IMPRINTS SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS.
49. ASSESSMENT OF MYOSITIS-RELATED INTERSTITIAL LUNG DISEASE BY 68GA-DATA.SA.FAPI PET-CT.
50. SAT0552 Fibroblast-Like Synovial Cells and Monocytes TEAM up in the Organization and the Dynamic Modeling of the Synovial Tissue
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.